Search Within

William Douglas Tap

Formats
  1. Journal Article (191)
  2. Meeting Abstract (159)
  3. Review (11)
  4. Book Section (4)
  5. Editorial (4)
  6. Guidelines (3)
  7. Miscellaneous (2)
  8. Research Letter (1)
Groups
  1. Department of Medicine (375)
  2. Sarcoma Service (375)
  3. Solid Tumor Oncology Division (375)
  4. GSK Faculty (158)
  5. Tow Center for Developmental Oncology (TCDO) (148)
  6. Department of Pathology and Laboratory Medicine (132)

More Groups

People
  1. Sandra D'Angelo (105)
  2. Cristina Antonescu (96)
  3. Mark Dickson (91)
  4. Samuel Singer (80)
  5. Mrinal Gounder (78)
  6. Mary Keohan (76)

More People

Years
  1. 2025 (17)
  2. 2024 (50)
  3. 2023 (34)
  4. 2022 (43)
  5. 2021 (25)
  6. 2020 (34)

More Years

Publications
  1. Journal of Clinical Oncology (102)
  2. Annals of Oncology (30)
  3. Clinical Cancer Research (27)
  4. Cancer Research (14)
  5. Modern Pathology (11)
  6. Lancet Oncology (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (109)
  2. American Association for Cancer Research (48)
  3. Oxford University Press (38)
  4. Elsevier Science, Inc. (22)
  5. Elsevier Inc. (20)
  6. Nature Publishing Group (19)

More Publishers

Results (375)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: A multicentre, open-label, phase 2 trial
    Journal Article

    Schwartz, G. K.; Tap, W. D.; Qin, L. X.; Livingston, M. B.; Undevia, S. D.; Chmielowski, B.; Agulnik, M.; Schuetze, S. M.; Reed, D. R.; Okuno, S. H.; more...
    Lancet Oncology (2013)

    Fulltext@MSK | Save
  • A phase Ib/II study evaluating the efficacy of doxorubicin (D) with or without a human anti-PDGFR alpha monoclonal antibody olaratumab (IMC-3G3) in the treatment of advanced soft tissue sarcoma (STS)
    Meeting Abstract

    Tap, W. D.; Van Tine, B. A.; Elias, A. D.; Livingston, M. B.; Agulnik, M.; Cooney, M. M.; Chmielowski, B.; Brenner, A. J.; Pennock, G. K.; Somaiah, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase II multicenter study of the IGF-1 receptor antibody cixutumumab (A12) and the mTOR inhibitor temsirolimus (TEM) in patients (pts) with refractory IGF-1R positive (+) and negative (-) bone and soft tissue sarcomas (STS)
    Meeting Abstract

    Schwartz, G. K.; Tap, W. D.; Qin, L. X.; Livingston, M. B.; Undevia, S. D.; Chmielowski, B.; Agulnik, M.; Schuetze, S.; Reed, D. R.; Okuno, S. H.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A first-in-human, phase Ib combination study to assess safety, pharmacokinetics (PK), and pharmacodynamics (PD) of a hedgehog inhibitor, GDC-0449, with a Notch inhibitor, RO4929097, in patients with advanced sarcoma
    Meeting Abstract

    Gounder, M. M.; Dickson, M. A.; Wu, N.; Ivy, S. P.; Carvajal, R. D.; D'Angelo, S. P.; Keohan, M. L.; Qin, L. X.; Erinjeri, J. P.; Takebe, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M. A.; Keohan, M. L.; Tap, W. D.; Antonescu, C.; Landa, J.; Qin, L. X.; Dohrenwend, E. G.; Rathbone, D.; Ustoyev, Y.; Condy, M. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Activity of sorafenib in radiation-associated breast angiosarcomas harboring MYC and FLT4 amplifications
    Meeting Abstract

    D'Angelo, S. P.; Antonescu, C. R.; Keohan, M. L.; Carvajal, R. D.; Dickson, M. A.; Gounder, M. M.; Moraco, N. H.; Singer, S.; Schwartz, G. K.; Tap, W. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Randomized phase III, multicenter, open-label study comparing TH-302 in combination with doxorubicin versus doxorubicin alone in subjects with locally advanced unresectable or metastatic soft tissue sarcoma
    Meeting Abstract

    Chawla, S. P.; Reinke, D. K.; Saks, S.; Kroll, S.; Tap, W. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Randomized multicenter double-blind phase II trial: The immunological adjuvant OPT-821 with or without a trivalent ganglioside vaccine in metastatic sarcoma patients following metastasectomy
    Meeting Abstract

    Carvajal, R. D.; Chugh, R.; Milhem, M. M.; Ryan, C. W.; George, S.; Chmielowski, B.; Agulnik, M.; Rodler, E. T.; Elias, A. D.; Budd, G. T.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • PDGFR as a novel target for the treatment of malignant peripheral nerve sheath tumors
    Meeting Abstract

    Patwardhan, P.; Tap, W.; de Stanchina, E.; Schwartz, G. K.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Functional analysis of gene expression profiling of primary and metastatic melanoma: Possible implications from BRAF mutant and wild-type cell lines
    Meeting Abstract

    Essner, R.; Gong, K. W.; Chmielowski, B.; Finn, R.; Tap, W. D.; Slamon, D.
    Cancer Research (2012)

    Fulltext@MSK | Save